MALAT1 and androgen insensitivity syndrome: Some limitations existed in our study: 1) the sample size (120 AIS patients) was relatively small, thus the statistical power might be low; 2) the median follow-up duration (25.0 months (range: 1.0-42.0 months)) was relatively short, thus the correlation of lnc-MALAT1 expression with long-term prognosis remains to be further investigated; and 3) detailed mechanism of lnc-MALAT1 in AIS is still unclear, and further study is still needed.